Provided by Tiger Fintech (Singapore) Pte. Ltd.

Windtree Therapeutics, Inc.

0.9726
-0.0274-2.74%
Post-market: 0.9604-0.0122-1.25%16:39 EDT
Volume:3.43M
Turnover:3.42M
Market Cap:11.26M
PE:-0.02
High:1.02
Open:1.01
Low:0.9600
Close:1.00
Loading ...

BNB Surges Nearly 5% — Breaks $800 to Set New All-Time High

TradingKey
·
Yesterday

BRIEF-Kraken And Windtree Therapeutics Announce Strategic Partnership For BNB Custody, Trading, And OTC Services

Reuters
·
22 Jul

Windtree Therapeutics Inc - Term Sheet Signed for $140 Mln Future Subscriptions

THOMSON REUTERS
·
22 Jul

Kraken and Windtree Therapeutics Announce Strategic Partnership for Bnb Custody, Trading, and Otc Services

THOMSON REUTERS
·
22 Jul

Windtree Therapeutics Secures $60 Million Investment to Launch BNB Crypto Treasury Strategy

Reuters
·
17 Jul

Windtree to Launch Bnb Crypto Treasury Strategy With Agreement for $60 Million Investment Led by Build and Build Corp. With up to $140 Million More in Follow on Subscriptions

THOMSON REUTERS
·
16 Jul

Windtree Therapeutics: Proceeds to Be Used to Launch Bnb Crypto Treasury Strategy & Purchase Bnb

THOMSON REUTERS
·
16 Jul

Windtree Therapeutics Inc - Enters Note Purchase Agreements on June 27, 2025 - SEC Filing

THOMSON REUTERS
·
04 Jul

Windtree Therapeutics Inc. Engages in Unregistered Sales of Equity Securities with Convertible Promissory Notes and Warrants Issued in June and July Transactions

Reuters
·
04 Jul

BRIEF-Windtree Announces Issuance Of Istaroxime Patent For The United States For Acute Heart Failure

Reuters
·
02 Jul

Windtree Therapeutics Inc - Istaroxime Patent Provides Protection Until 2039

THOMSON REUTERS
·
02 Jul

Windtree Therapeutics Inc - Istaroxime Approaching Phase 3 Readiness in Cardiogenic Shock

THOMSON REUTERS
·
02 Jul

Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure

THOMSON REUTERS
·
02 Jul

BRIEF-Windtree Therapeutics Inc - Interim Analysis To Assess Safety, Tolerability, And Preliminary Efficacy

Reuters
·
30 Jun

Windtree Therapeutics Inc - Reaches Planned Enrollment of 20 Patients for Seismic C Study

THOMSON REUTERS
·
30 Jun

Windtree Therapeutics Inc - Data Expected to Be Useful for End of Phase 2 Meeting With FDA

THOMSON REUTERS
·
30 Jun

Windtree Therapeutics Inc - Interim Analysis to Assess Safety, Tolerability, and Preliminary Efficacy

THOMSON REUTERS
·
30 Jun

Windtree Therapeutics Inc. Issues Convertible Promissory Notes and Warrants for Common Stock in Recent Share Transactions

Reuters
·
28 Jun

Windtree Contracts Chinese Firm to Make Evofem's Contraceptive

Dow Jones
·
27 Jun

Windtree Therapeutics: Contract Inked With Outside U.s Manufacturer to Cut Phexxi Manufacturing Costs by Over 50% by End of 2026

THOMSON REUTERS
·
27 Jun